Mualliflar

  • Дилфуза Сабуровна Маткаримова
  • Дилбар Эркиновна Джураева
  • Мавлюда Илхамовна Набиева

##semicolon##

иммунная тромбоцитопения, распространенность, частота встречаемости, дети, взрослые.

##submission.citations##

Зотова И. И. Клинические и молекулярно-генетические показатели тяжести течения и эффективности терапии у больных иммунной тромбоцитопенией. Автореф. дис. С-Петербург, 2018. С. 22.

Зотова И.И. Аллельный полиморфизм гена GPIIB как фактор, ассоциированный с вероятностью развития иммунной тромбоцитопении и тяжестью геморрагического синдрома/ И.И. Зотова, С.И. Капустин, С.В. Грицаев, Н.В. Минеева, И.И. Кробинец, Ж.Ю. Сидорова, С.С. Бессмельцев, А.В. Чечеткин // Онкогематология. – 2018. – Т. 13, № 2. – С.93-99.

Altomare I. et al. Rate of bleeding-related episodes in adult patients with primary immune thrombocytopenia: a retrospective cohort study using a large administrative medical claims database in the US //Clinical epidemiology. – 2016. – С. 231-239.

Christiansen C. F. et al. Chronic immune thrombocytopenia in Denmark, Sweden and Norway: the Nordic country patient registry for romiplostim//EClinicalMedicine.– 2019. – Т. 14. – С. 80-87.

Cooper N., Ghanima W. Immune thrombo-cytopenia //New England Journal of Medicine. – 2019. – Т. 381. – №. 10. – С. 945-955.

Doobaree I. U. et al. Thromboembolism in adults with primary immune thrombocytopenia: a systematic literature review and meta‐analysis //European journal of haematology. – 2016. – Т. 97. – №. 4. – С. 321-330.

Kohli R., Chaturvedi S. Epidemiology and clinical manifestations of immune thrombocytopenia //Hämostaseologie. – 2019. – Т. 39. – №. 03. – С. 238-249.

Koylu A. et al. Immune thrombocytopenia: epidemiological and clinical features of 216 patients in northwestern Turkey //Annals of hematology. – 2015. – Т. 94. – С. 459-466.

Lebrun D. et al. Epidemiology of autoimmune and inflammatory diseases in a French nationwide HIV cohort //Aids. – 2017. – Т. 31. – №. 15. – С. 2159-2166.

Lim J. H. et al. Epidemiology and viral etiology of pediatric immune thrombocytopenia through Korean public health data analysis //Journal of Clinical Medicine. – 2021. – Т. 10. – №. 7. – С. 1356.

Melikyan A. L. et al. Incidence of Primary Immune Thrombocytopenia (ITP) in adults in one region of Russia //Blood. – 2016. – Т. 128. – №. 22. – С. 4941.

Moulis G. et al. Epidemiology of incident immune thrombocytopenia: a nationwide population-based study in France //Blood, The Journal of the American Society of Hematology. – 2014. – Т. 124. – №. 22. – С. 3308-3315.

Moulis G., Comont T., Adoue D. New insights into the epidemiology of immune thrombocy-topenia in adult patients: Impact for clinical practice //La Revue de Médecine Interne. – 2021. – Т. 42. – №. 1. – С. 11-15.

Okubo Y., Handa A. Nationwide trend analysis of pediatric inpatients with immune thrombocy-topenia in the United States //Journal of pediatric hematology/oncology. – 2018. – Т. 40. – №. 3. – С. e140-e144.

Pavord S. et al. Clinical features of vaccine-induced immune thrombocytopenia and thrombosis //New England Journal of Medicine. – 2021. – Т. 385. – №. 18. – С. 1680-1689., Cooper N., Ghanima W. Immune thrombocytopenia //New England Journal of Medicine. – 2019. – Т. 381. – №. 10. – С. 945-955.

Pietras N. M., Pearson-Shaver A. L. Immune thrombocytopenic purpura //StatPearls [Internet]. – StatPearls Publishing, 2022.

Rodeghiero F., Marranconi E. Management of immune thrombocytopenia in women: current standards and special considerations //Expert Review of Hematology. – 2020. – Т. 13. – №. 2. – С. 175-185.

Sugiura T. et al. Immune thrombocytopenic purpura detected with oral Hemorrhage: A case report //Journal of Dentistry. – 2018. – Т. 19. – №. 2. – С. 159.